Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Introduction Pulmonary hypertension (PH) associated with chronic lung disease (CLD) and/or hypoxia (World Health Organization (WHO) Group 3 PH) is a highly morbid condition, with mortality risk exceeding that of pulmonary arterial hypertension (PAH) by 5-fold [1–3]. Currently, the cornerstone of treatment for Group 3 PH is optimising the underlying lung disease or lung transplantation for eligible patients [4, 5].
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
